Abstract
This Expert's Comment discusses the Grand Rounds Case entitled “Minimal Access Bilateral Transforaminal Lumbar Interbody Fusion for High-Grade Isthmic Spondylolisthesis” by Nasir A Quraishi and Raja Y Rampersaud. It puts a technically elegant surgical method for minimally invasive reduction and arthrodesis of isthmic spondylolistheses into the context of short and long term outcomes and questions the motivations for performing such minimally invasive procedures in the absence of any proven mid or long term advantages over more traditional techniques. In addition, the use of BMP in spinal arthrodesis is discussed on the background of recently published IPD metaanalyses from the Infuse™ spinal FDA trials.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Quraishi NA, Rampersaud YR (2013) Minimal access bilateral transforaminal lumbar interbody fusion for high-grade isthmic spondylolisthesis. Eur Spine J 22(8):1693–1699
Archavlis E, Carvi YNM (2013) Comparison of minimally invasive fusion and instrumentation versus open surgery for severe stenotic spondylolisthesis with high-grade facet joint osteoarthritis. Eur Spine J
Kotani Y, Abumi K, Ito M, Sudo H, Abe Y, Minami A (2012) Mid-term clinical results of minimally invasive decompression and posterolateral fusion with percutaneous pedicle screws versus conventional approach for degenerative spondylolisthesis with spinal stenosis. Eur Spine J 21:1171–1177
Parker SL, Mendenhall SK, Shau DN, Zuckerman SL, Godil SS, Cheng JS, McGirt MJ (2013) Minimally Invasive versus open transforaminal lumbar interbody fusion (TLIF) for degenerative spondylolisthesis: comparative effectiveness and cost-utility analysis. World Neurosurg
Pelton MA, Phillips FM, Singh K (2012) A comparison of perioperative costs and outcomes in patients with and without workers’ compensation claims treated with minimally invasive or open transforaminal lumbar interbody fusion. Spine (Phila Pa 1976) 37:1914–1919
Parker SL, Adogwa O, Bydon A, Cheng J, McGirt MJ (2012) Cost-effectiveness of minimally invasive versus open transforaminal lumbar interbody fusion for degenerative spondylolisthesis associated low-back and leg pain over two years. World Neurosurg 78:178–184
McGirt MJ, Parker SL, Lerner J, Engelhart L, Knight T, Wang MY (2011) Comparative analysis of perioperative surgical site infection after minimally invasive versus open posterior/transforaminal lumbar interbody fusion: analysis of hospital billing and discharge data from 5170 patients. J Neurosurg Spine 14:771–778
Wang J, Zhou Y, Zhang ZF, Li CQ, Zheng WJ, Liu J (2010) Comparison of one-level minimally invasive and open transforaminal lumbar interbody fusion in degenerative and isthmic spondylolisthesis grades 1 and 2. Eur Spine J 19:1780–1784
Simmonds MC, Brown JV, Heirs MK, Higgins JP, Mannion RJ, Rodgers MA, Stewart LA (2013) Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data. Ann Intern Med 158:877–889
Fu R, Selph S, McDonagh M, Peterson K, Tiwari A, Chou R, Helfand M (2013) Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis. Ann Intern Med 158:890–902
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Birkenmaier, C. Expert’s comment concerning Grand Rounds case entitled “Minimal access bilateral transforaminal lumbar interbody fusion for high-grade isthmic spondylolisthesis” (by Nasir A. Quraishi and Y. Raja Rampersaud; doi:10.1007/s00586-012-2623-2). Eur Spine J 22, 1714–1716 (2013). https://doi.org/10.1007/s00586-013-2891-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-013-2891-5